Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Pathology|September 25, 2020
Biospecimen Collection During the COVID-19 PandemicHeather A Lankes, Hala Makhlouf
Nucleic Acids Research|October 15, 2005
A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambdaChristine N Zanghi, Heather A Lankes, Birgit Bradel-Tretheway, et al.
Cancer Causes & Control : CCC|November 18, 2008
Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control studyHeather A Lankes, Angela J Fought, Andrew M Evens, et al.
Breast Cancer Research and Treatment|December 22, 2007
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk womenDeepa B Patil, Heather A Lankes, Ritu Nayar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 19, 2009
Ductal lavage is an inefficient method of biomarker measurement in high-risk womenSeema A Khan, Heather A Lankes, Deepa B Patil, et al.
Gynecologic Oncology|May 28, 2015
Minority participation in Gynecologic Oncology Group (GOG) StudiesJennifer Scalici, Michael A Finan, Jennifer Black, et al.
Vaccine|February 13, 2007
Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivoChristine M Malboeuf, David A L Simon, Young-Eun Ellen Lee, et al.
Gynecologic Oncology|November 26, 2015
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group studyRodney P Rocconi, Heather A Lankes, William E Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2015
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group StudyRamez N Eskander, Shamshad Ali, Thanh Dellinger, et al.
Gynecologic Oncology|March 27, 2012
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group studyMichael A Gold, William E Brady, Heather A Lankes, et al.
Pageof 7